Prophylactic treatment with TH5487 and rIFN-λ directly to the upper respiratory tract resulted in increased expression of Isg15, Oas1a and Rsad2. This effect was partially abrogated in mice treated with the neutralizing antibody on day 1 post-infection (Figure 7B). Here, ISG15 is linked to infection.